Skip To Main Content
Hua Yin on Muck Rack

Hua Yin

As seen in: Nature, Wiley Online Library, Frontiers in Nutrition, MDPI, ACS Publications, Royal Society of Chemistry, Canadian Journal of Infectious Diseases & Medical Microbiology, International Journal of Analytical Chemistry, Indian Journal of Pharmaceutical Sciences
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hua

Contact Hua, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Convergent functional, white-matter microstructural, and cerebral perfusion abnormalities in overweight and obese adults: a multimodal MRI study

|
By Hua Yin, Yuanyuan Yi, Yuhang Yu, Xiaohui Wu, Lifeng Huang, Wenqi Qin, Mi Qin, Ke Ding, Lingqianhui Liu, Ruisui Huang
| Frontiers in Nutrition
Abstract Background: Obesity affects the brain, but most neuroimaging studies examine a single modality, leaving it unclear whether obesity-related functional, microstructural, and perfusion abnormalities co-localize. We combined three modalities across the normal-weight–overweight–obese spectrum.
Open in Who Shared Issue with article?

Polystyrene Nanoplastics Impair Transcriptional Resilience to Salt Stress in Rice Click to copy article link Article link copied!

|
By Chanchan Xu, Shaoyu Tang, Hua Yin
| dx.doi.org
Open in Who Shared Issue with article?

Penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in newly diagnosed primary central nervous system lymphoma (PCNSL): a phase 2 trial | Blood Cancer Journal

|
By Hao-Rui Shen, Hua Yin, Kai-Xin Du, Yi-Fan Wu, Wei Hua, YUE LI, Xin-Yu Zhang, Rui Gao, Jian-Yong Li, Li Wang, Jin-Hua Liang, Wei Xu, Jia-Zhu Wu, Luthuli Sibusiso, Yi-Lin Kong
| Nature Verified
Abstract This clinical trial (NCT05347641) evaluated efficacy and safety of penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in patients with newly diagnosed (ND) primary central nervous system lymphoma (PCNSL). Patients received an induction treatment of six cycles of Pen-RMA every 3 weeks.
Open in Who Shared Issue with article?
See all 20 licensed articles (24 Total)